Vemurafenib pharmacokinetics and its correlation with efficacy and safety in outpatients with advanced BRAF-mutated melanoma
Crossref DOI link: https://doi.org/10.1007/s11523-015-0375-8
Published Online: 2015-07-25
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kramkimel, N.
Thomas-Schoemann, A.
Sakji, L.
Golmard, JL.
Noe, G.
Regnier-Rosencher, E.
Chapuis, N.
Maubec, E.
Vidal, M.
Avril, MF.
Goldwasser, F.
Mortier, L.
Dupin, N.
Blanchet, B.
Text and Data Mining valid from 2015-07-25